[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-368061-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-368061-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","cbx4-drives-gastric-cancer-progression-by-activating-catenin-signaling-abstract-introduction-and-background","CBX4 Drives Gastric Cancer Progression by Activating β-Catenin Signaling - Abstract, Introduction, and Background","","Chromobox 4 (CBX4), a polycomb protein family member implicated in tumor pathogenesis, is examined for its role in gastric cancer (GC) progression and as a potential therapeutic target. CBX4 expression was compared between GC tissues and adjacent non-cancerous tissues and between GC cell lines and normal gastric epithelial cells, with clinicopathological correlations assessed. Cellular and in vivo assays used knockdown and overexpression, evaluating proliferation, migration, invasion, xenograft tumor growth, β-catenin activity, and dependency on Wnt/β-catenin signaling via XAV939. Results show CBX4 upregulation predicts aggressive features and promotes oncogenic phenotypes through β-catenin activation.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/cbx4-drives-gastric-cancer-progression-by-activating-catenin-signaling-abstract-introduction-and-background/368061/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/cbx4-drives-gastric-cancer-progression-by-activating-catenin-signaling-abstract-introduction-and-background/368061.png","ImageObject",300,407,{"name":42,"@type":43},"anakgang17","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-29","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",8,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What was the main objective of the study on CBX4 in gastric cancer?","Question",{"text":63,"@type":64},"To investigate how CBX4 contributes to gastric cancer progression, clarify the underlying mechanism, and assess CBX4 as a potential therapeutic target.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How was CBX4 functionally tested in relation to tumor behavior?",{"text":68,"@type":64},"Through CBX4 knockdown and overexpression in vitro assays (proliferation, migration, invasion) and in vivo xenograft tumorigenesis in nude mice.",{"name":70,"@type":61,"acceptedAnswer":71},"What mechanism connects CBX4 to gastric cancer progression?",{"text":72,"@type":64},"CBX4 promotes progression by activating β-catenin signaling, shown by changes in total and nuclear β-catenin levels and transcriptional activity.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},368061,1790219343,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":55,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},962090883568,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","Tech Science Press  \n| Doi:10.32604/or.2025.068651\u003Cbr>ARTICLE |  |\n| --- | --- |\n|  | \u003Cbr>|\n| CBX4 Drives Gastric Cancer Progression by Activating β-Catenin Signaling Wendong Jia\\#, Ting Zhang\\#, Ziying Zhang, Lingzhi Wu, Xihao Fu, Zhenxin Wang* and Ni Yin*\u003Cbr>Department of Oncology, The First Affiliated Hospital of Soochow University, Suzhou, 215006, China\u003Cbr>*Corresponding Authors: Zhenxin Wang. Email: [zhenxw316@163.com](zhenxw316@163.com); Ni Yin. Email: [yn18626206878@163.com](yn18626206878@163.com)\u003Cbr>\\# These authors contributed equally to this work\u003Cbr>Received: 03 June 2025; Accepted: 27 August 2025; Published: 30 December 2025\u003Cbr>ABSTRACT: Objectives: Chromobox 4 (CBX4), a polycomb protein family member linked to tumor pathogenesis via dysregulation, has an incompletely defined role in gastric cancer (GC) . The study aimed to investigate the role and mechanism of CBX4 in GC progression and evaluate its potential as a therapeutic target. Methods: CBX4 expression was assessed in GC tissues vs. adjacent non-cancerous tissues and in GC cell lines vs. normal gastric mucosal epithelial cells. Clinicopathological correlations were analyzed. Functional impacts ofCBX4 were determined using knockdown and overexpression models in vitro (cell proliferation, migration, invasion) and in vivo (xenograft tumorigenesis in nude mice). Mechanistic studies evaluated β-catenin levels (total and nuclear) and transcriptional activity following CBX4 modulation. The functional dependency on Wnt/β-catenin signaling was tested using the pharmacological inhibitor XAV939 in CBX4-overexpressing cells. Results: CBX4 expression was significantly upregulated in GC tissues and cell lines. Elevated CBX4 levels strongly correlated with aggressive tumor characteristics, including larger tumor size, lymph node metastasis, and advanced Tumor, Node, Metastasis (TNM) stage. Functionally, CBX4 knockdown suppressed GC cell proliferation, migration, invasion in vitro, and tumorigenesis in vivo. Conversely, CBX4 overexpression enhanced these malignant traits. Mechanistically, CBX4 depletion reduced total and nuclear β-catenin levels and inhibited its transcriptional activity, while CBX4 overexpression had the opposite effect. Critically, XAV939-mediated inhibition of Wnt/β-catenin signaling attenuated the oncogenic effects induced by CBX4 overexpression. Conclusion: CBX4 upregulation promotes GC progression via β-catenin signaling activation. The CBX4/β-catenin axis emerges as a promising therapeutic target, offering potential for the development of precision treatment strategies in GC management.\u003Cbr>KEYWORDS: Gastric cancer (GC); chromobox 4 (CBX4); proliferation; metastasis; β-catenin |  |\n\n1 Introduction  \nAs the fifth most frequently diagnosed cancer globally, gastric cancer (GC) represents a significant contributor to the global disease burden, ranking as the fifth leading cause of cancer-related mortality [1] . Notably, China faces an alarmingly disproportionate share of this burden, accounting for nearly half of all newly diagnosed cases and associated deaths worldwide [2] . According to the World Health Organization (WHO) data (2020), GC is associated with 479,000 new cases and 374,000 deaths annually, positioning it as the fourth most prevalent malignancy in the nation and the third leading cause of cancer-related mortality [3] . Despite recent therapeutic advancements, including the integration of surgery with adjuvant therapies such as chemotherapy, the prognosis for GC patients remains unsatisfactory [4,5] . Consequently, there is an urgent need to delve deeper into the molecular mechanisms underlying the onset and malignant progression of GC. Such insights are crucial for identifying promising biomarkers for early diagnosis and validating critical therapeutic targets to improve intervention strategies and enhance patient outcomes.  \nCopyright © 2026 The Authors. Published by Tech Science Press.  \nThis work is licensed under a Creative Commons Attrib","cbCainDGMwTPgkf8","https://ap.wps.com/l/cbCainDGMwTPgkf8","pdf",14194878,18,"English","# Abstract\n# Keywords\n# 1 Introduction","[{\"question\":\"What was the main objective of the study on CBX4 in gastric cancer?\",\"answer\":\"To investigate how CBX4 contributes to gastric cancer progression, clarify the underlying mechanism, and assess CBX4 as a potential therapeutic target.\"},{\"question\":\"How was CBX4 functionally tested in relation to tumor behavior?\",\"answer\":\"Through CBX4 knockdown and overexpression in vitro assays (proliferation, migration, invasion) and in vivo xenograft tumorigenesis in nude mice.\"},{\"question\":\"What mechanism connects CBX4 to gastric cancer progression?\",\"answer\":\"CBX4 promotes progression by activating β-catenin signaling, shown by changes in total and nuclear β-catenin levels and transcriptional activity.\"}]","CBX4 Drives Gastric Cancer Progression by Activating β-Catenin Signaling - Abstract, Introduction, and Background | PDF",1790174780,45,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b3bb2b7cccd4d08b69f0cfceb7c8b4a5.webp",983,1271,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b63d59b2c05137f82555dde9a2443453.webp",982,1270,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f98ec2052525884a3f1844f679b5d133.webp",981,1269,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b7e97922c0974178e04b2ca64d13f445.webp",980,1267]